ICD-10-CM Codes that Support Medical Necessity For monitoring of patient compliance in a drug treatment program, use diagnosis code Z03. 89 as the primary diagnosis and the specific drug dependence diagnosis as the secondary diagnosis.
Other abnormal findings in specimens from other organs, systems and tissues. R89. 8 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. The 2022 edition of ICD-10-CM R89.
Z51. 81 Encounter for therapeutic drug level monitoring - ICD-10-CM Diagnosis Codes.
2022 ICD-10-CM Diagnosis Code R79. 1: Abnormal coagulation profile.
ICD-10-CM Code for Encounter for preprocedural laboratory examination Z01. 812.
Encounter for other specified special examinationsICD-10 code Z01. 89 for Encounter for other specified special examinations is a medical classification as listed by WHO under the range - Factors influencing health status and contact with health services .
Therapeutic drug monitoring (TDM) is testing that measures the amount of certain medicines in your blood. It is done to make sure the amount of medicine you are taking is both safe and effective. Most medicines can be dosed correctly without special testing.
Quantitation of detected drugs is not reimbursable. Code 82205 is for therapeutic monitoring only.
V58. 69 - Long-term (current) use of other medications. ICD-10-CM.
NCD - Partial ThromboplastinTime (PTT) (190.16)
The partial thromboplastin time (PTT; also known as activated partial thromboplastin time (aPTT)) is a screening test that helps evaluate a person's ability to appropriately form blood clots. It measures the number of seconds it takes for a clot to form in a sample of blood after substances (reagents) are added.
An abnormal coagulation profile with high prothrombin time (PT), international normalized Ratio (INR) and PTT usually indicates an associated liver disorder, with cirrhosis and portal hypertension as the etiology of splenomegaly.
Abnormal finding of blood chemistry, unspecified The 2022 edition of ICD-10-CM R79. 9 became effective on October 1, 2021.
Your lab results may also include one of these terms: Negative or normal, which means the disease or substance being tested was not found. Positive or abnormal, which means the disease or substance was found.
Z71. 2 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. The 2022 edition of ICD-10-CM Z71. 2 became effective on October 1, 2021.
9: Fever, unspecified.
Abnormal findings on neonatal screening 1 P09 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. 2 The 2021 edition of ICD-10-CM P09 became effective on October 1, 2020. 3 This is the American ICD-10-CM version of P09 - other international versions of ICD-10 P09 may differ.
In most cases the manifestation codes will have in the code title, "in diseases classified elsewhere.". Codes with this title are a component of the etiology/manifestation convention. The code title indicates that it is a manifestation code.
R82.5 is a billable diagnosis code used to specify a medical diagnosis of elevated urine levels of drugs, medicaments and biological substances. The code R82.5 is valid during the fiscal year 2021 from October 01, 2020 through September 30, 2021 for the submission of HIPAA-covered transactions.#N#The ICD-10-CM code R82.5 might also be used to specify conditions or terms like acetaminophen in urine, amphetamine in urine, drug level in urine specimen above therapeutic range, drug, medicament, or biological substance in urine above reference range, high 17-ketosteroid level in urine , high catecholamine level in urine, etc.
The Tabular List of Diseases and Injuries is a list of ICD-10 codes, organized "head to toe" into chapters and sections with coding notes and guidance for inclusions, exclusions, descriptions and more. The following references are applicable to the code R82.5:
Z13.9 is a valid billable ICD-10 diagnosis code for Encounter for screening, unspecified . It is found in the 2021 version of the ICD-10 Clinical Modification (CM) and can be used in all HIPAA-covered transactions from Oct 01, 2020 - Sep 30, 2021 .
DO NOT include the decimal point when electronically filing claims as it may be rejected. Some clearinghouses may remove it for you but to avoid having a rejected claim due to an invalid ICD-10 code, do not include the decimal point when submitting claims electronically. See also: Screening (for) Z13.9.